1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
2343.50 -24.10 (-1.02%)
335.6K
NSE+BSE Volume

NSE 25 Jun, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Lupin gets US FDA approval for Enzalutamide tablets ANDA, targeting a $3.7 bn market as of 2025 See details